 CANTON, Mass., March 08, 2022 GLOBE NEWSWIRE -- Organogenesis Holdings Inc. Nasdaq: ORGO, a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will participate in Oppenheimers 32nd Annual Healthcare Conference, which is being held virtually from March 15th-16th. Management will present on Tuesday, March 15th at 10:40 a.m. Eastern Time. 